Approximately 1 million Aetna members will need new coverage with the announcement that CVS will be leaving the Affordable ...

Patients with neovascular age-related macular degeneration (nAMD) experienced improvements in central macular thickness and ...

Experts urge for technology-driven, collaborative solutions as patients shoulder a growing burden of prescription costs.

Because clinical trials do not mimic the real-world application of multiple myeloma treatments, Ajai Chari, MD, discussed the variety of patient factors clinicians should consider in their practice.

Experts champion medically integrated care and oncology optimized distribution models as vital strategies to improve outcomes, streamline access, and reduce costs for patients.

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

Improving health equity is part of the core of quality improvement and requires data collection and community engagement ...

Infection was a leading cause of death in lower-risk myelodysplastic syndromes (MDS), highlighting the need for vigilant ...

Key trends and challenges are shaping the next era of advanced therapies, from FDA momentum to broader patient access.

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older ...

An increase in hospitalizations related to respiratory disease was found in older adults in the western US. “This information ...

Results presented on Tuesday at the American Association for Cancer Reserch include data on the combined use of tissue and ...